scholarly article | Q13442814 |
P50 | author | Emily Chew | Q24266614 |
Elvira Agrón | Q83234331 | ||
Age-Related Eye Disease Study Research Group | Q83234373 | ||
Traci E Clemons | Q92993074 | ||
Frederick Ferris | Q96025318 | ||
John Paul SanGiovanni | Q114678175 | ||
Robert D Sperduto | Q114678183 | ||
P2093 | author name string | Matthew D Davis | |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | eye disease | Q3041498 |
macular degeneration | Q27429789 | ||
P304 | page(s) | 272-277 | |
P577 | publication date | 2014-03-01 | |
P1433 | published in | JAMA Ophthalmology | Q4787301 |
P1476 | title | Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36. | |
P478 | volume | 132 |
Q35918499 | 4-Acetoxyphenol Prevents RPE Oxidative Stress-Induced Necrosis by Functioning as an NRF2 Stabilizer |
Q38898742 | A Revised Hemodynamic Theory of Age-Related Macular Degeneration |
Q92214955 | A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration |
Q39786855 | Age-related macular degeneration in patients with uveitis |
Q38653249 | Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. |
Q33892164 | Ascorbic acid concentrations in aqueous humor after systemic vitamin C supplementation in patients with cataract: pilot study |
Q92524759 | Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39 |
Q38877436 | Bivariate Analysis of Age-Related Macular Degeneration Progression Using Genetic Risk Scores |
Q45935732 | Brimonidine Can Prevent In Vitro Hydroquinone Damage on Retinal Pigment Epithelium Cells and Retinal Müller Cells. |
Q35061844 | Carotenoids: potential allies of cardiovascular health? |
Q28244515 | Choroid, Haller's, and Sattler's layer thickness in intermediate age-related macular degeneration with and without fellow neovascular eyes |
Q53099086 | Choroidal structure in eyes with drusen and reticular pseudodrusen determined by binarisation of optical coherence tomographic images. |
Q101051227 | Deep phenotype unsupervised machine learning revealed the significance of pachychoroid features in etiology and visual prognosis of age-related macular degeneration |
Q38789140 | Dry Age-Related Macular Degeneration Pharmacology |
Q49223224 | Effect of Anti-C5a Therapy in a Murine Model of Early/Intermediate Dry Age-Related Macular Degeneration. |
Q47104771 | Effect of neuroactive nutritional supplementation on body weight and composition in growing puppies |
Q47355167 | Gaming to improve vision: 21st century self-monitoring for patients with age-related macular degeneration. |
Q64235139 | Human complement factor H Y402H polymorphism causes an age-related macular degeneration phenotype and lipoprotein dysregulation in mice |
Q36844624 | Hypoxia-induced metabolic stress in retinal pigment epithelial cells is sufficient to induce photoreceptor degeneration |
Q33758205 | Immune responses in age-related macular degeneration and a possible long-term therapeutic strategy for prevention |
Q36811078 | Impairments in Dark Adaptation Are Associated with Age-Related Macular Degeneration Severity and Reticular Pseudodrusen |
Q30829406 | Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up |
Q88985491 | Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes |
Q37613100 | Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study |
Q26782061 | Marine Carotenoids against Oxidative Stress: Effects on Human Health |
Q39633569 | Monomeric C-reactive protein and inflammation in age-related macular degeneration |
Q89687694 | Nutritional Supplements for Age-Related Macular Degeneration |
Q60922653 | OCT Angiography and Cone Photoreceptor Imaging in Geographic Atrophy |
Q93196288 | Pachydrusen: the epidemiology of pachydrusen and its relevance to progression of pachychoroid disease spectrum |
Q92516024 | Progression of subclinical choroidal neovascularization in age-related macular degeneration |
Q34274040 | Projected changes in age-related macular degeneration and driving license holders in Finland |
Q41532061 | Recent developments in age-related macular degeneration: a review. |
Q89531841 | Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles |
Q89454097 | Systemic Disease and Long-term Intraocular Pressure Mean, Peak, and Variability in Nonglaucomatous Eyes |
Q41170382 | Taxifolin protects RPE cells against oxidative stress-induced apoptosis |
Q37412560 | The Age-Related Macular Degeneration Complex: Linking Epidemiology and Histopathology Using the Minnesota Grading System (The Inaugural Frederick C. Blodi Lecture). |
Q35744184 | The Effect of Zeaxanthin on the Visual Acuity of Zebrafish. |
Q38692816 | The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases. |
Q47418164 | The Relationship Between Plasma Concentrations of Lutein and Zeaxanthin with Self-Reported and Actual Prevalence of AMD in an Irish Population-Based Sample |
Q49350422 | The fate of eyes with wet AMD beyond four years of anti-VEGF therapy. |
Q39024579 | The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target |
Q64076633 | Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules |
Q52563441 | Treatment of Macular Degeneration with Sildenafil: Results of a Two-Year Trial. |
Q54986895 | Visual acuity and contrast sensitivity are two important factors affecting vision-related quality of life in advanced age-related macular degeneration. |
Q53018746 | [Atrophy of the macula in the context of its wet, age-related degeneration : An inescapable consequence of anti-VEGF therapy?] |
Search more.